Conexeu Sciences Inc. - Common Stock (CNXU)
9.8300
-0.6800 (-6.47%)
NASDAQ· Last Trade: Jul 18th, 12:04 PM EDT
Detailed Quote
| Previous Close | 10.51 |
|---|---|
| Open | 10.29 |
| Bid | 9.800 |
| Ask | 10.53 |
| Day's Range | 9.450 - 10.29 |
| 52 Week Range | 8.140 - 18.79 |
| Volume | 107,590 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 107,013 |
Chart
News & Press Releases
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday's regular session. The market value of their outstanding shares is at $24.9 million. Conexeu Sciences (NASDAQ:CNXU)
Via Benzinga · July 15, 2026
Issued on behalf of Conexeu Sciences Inc.
By Energy Metal News · Via GlobeNewswire · July 15, 2026
Issued on behalf of Conexeu Sciences Inc.
By Biotech Insider · Via GlobeNewswire · July 1, 2026
Issued on behalf of Conexeu Sciences Inc.
By Biotech Insider · Via GlobeNewswire · June 25, 2026
Issued on behalf of Conexeu Sciences Inc.
By Biotech Insider · Via GlobeNewswire · June 18, 2026
Issued on behalf of Conexeu Sciences Inc.
By World Street Intelligence · Via GlobeNewswire · June 16, 2026
Issued on behalf of Conexeu Sciences Inc.
By Equity Insider · Via GlobeNewswire · June 9, 2026
Weiss Ratings analyst Chris Graebe outlines how Regulation A offerings let retail investors access private companies like FJET, NUCL, and CNXU before their public listings.
Via MarketBeat · June 4, 2026
Issued on behalf of Conexeu Sciences Inc.
By Biotech Insider · Via GlobeNewswire · May 27, 2026
Issued on behalf of Conexeu Sciences Inc.A biotech debut out of Reno is betting that the next wave of medicine won’t replace tissue — it’ll grow it back.NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary — Somewhere between a 3D printer, a stem cell lab, and an operating room, a quiet shift has been building in medicine. The premise is no longer to put something foreign into the body when tissue is lost. The premise is to give the body the scaffolding, the cues, and the conditions it needs to grow back what was taken — and then have that scaffolding dissolve, leaving only the patient’s own living tissue behind.On May 21, 2026, a new Nasdaq ticker put a public-market price on that idea.
By Energy Metal News · Via GlobeNewswire · May 22, 2026
Issued on behalf of Conexeu Sciences Inc.
By World Street Intelligence · Via GlobeNewswire · May 22, 2026
Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue...
Via Newsfile · May 21, 2026